Q5141 Injection adalimumab-aaty, 1 milligrams
Also known as: Adalimumab-aaty injection, TNF inhibitor
Injection of adalimumab-aaty biosimilar per 1 milligram, a TNF inhibitor for immunosuppressive therapy.
In Plain Language
anti-inflammatory biologic; immune modulator
Clinical Context
Indicated for rheumatoid arthritis, plaque psoriasis, Crohn's disease, and ankylosing spondylitis.
RVU Information
CPT Q5141 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5141?
CPT Q5141 (Injection adalimumab-aaty, 1 milligrams) is a Q Codes code. Injection of adalimumab-aaty biosimilar per 1 milligram, a TNF inhibitor for immunosuppressive therapy.
Is Q5141 covered by insurance?
Q5141 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Indicated for rheumatoid arthritis, plaque psoriasis, Crohn's disease, and ankylosing spondylitis.
When is CPT Q5141 used?
Indicated for rheumatoid arthritis, plaque psoriasis, Crohn's disease, and ankylosing spondylitis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.